網路內科繼續教育
有效期間:民國 95年08月16日 95年08月31日

    Case Discussion

<Chief complaint>

Recurrent bilateral flank soreness for one year.

<Brief History>

A 58-year-old woman had been healthy before until one year ago when she suffered from bilateral flank soreness, gross hematuria and dysuria. She characterized the discomfort as a constant dull ache accompanied by mild nausea. Besides, she also complained of polyuria and polydipsia for a long time. She visited a local hospital where urinalysis showed many neutrophils and red blood cells, while plain abdominal roentogenograms showed bilateral renal opacities, indicating the diagnosis of urolithiasis with urinary tract infection (UTI). She received empirical antibiotic treatment and then underwent extracorporeal shock wave lithotripsy (ESWL). She had experienced another three episodes of flank soreness related to urolithiasis since then. Because of recurrent bilateral flank soreness, urolithiasis and UTI, she visited a professional clinic where elevation of serum calcium level (2.77 mmol/L) was noted. Under the impression of hypercalcemia with recurrent urolithiasis, she was admitted for further management.

Throughout her disease course, there was no hypertension, peptic ulcer disease, fracture, constipation or abdominal pain. She denied smoking, medication, alcohol consumption, calcium or vitamin supplementation and a family history of hypercalcemia.

Physical examination revealed a well-nourished woman whose consciousness was clear, blood pressure was 120/80 mmHg, respiratory rate was 18/min, pulse rate was 82/min and temperature was 36.5℃. The conjunctivae were pink, the sclerae were anicteric and the pupils were isocoric with prompt light reflex. The neck was supple without a goiter, palpable masses, lymphadenopathy or engorged jugular veins. The chest, abdomen, back, extremities and skin were all unremarkable.

<Laboratory data>

1. CBC/DC
WBC RBC HB HCT MCV MCHC PLT
K/μL M/μL g/dL  fL g/dL K/μL
5.38 3.87 12.0 33 91.6 33.4 348

2. BCS+e-
ALB TP T-Bil AST ALT ALP γ-GT Glucose
g/dL g/dL mg/dL U/L U/L U/L U/L mg/dL
4.1 7.0 0.4 27 25 430 25 90

UN CRE Na K Ca P Cl iPTH
mg/dL mg/dL mmol/L mmol/L mmol/L mg/dL mmol/L pg/mL
(12-72)
17.6 0.7 140 4.1 3.13 2.7 109 141

3. Urinalysis
Appearance Sp. Gr pH Protein Glucose Ketone  Crystal
      g/dL   mg/dL Ca-OX
Y;C 1.024 6.0 - - - 3+

Urobilirubin Bilirubin Nitrate WBC RBC Epi  Cast
          HPF  
1.0 - - 35-50 25-35 3-5 -


<Course & treatment>

The patient's serum biochemistries revealed hypercalcemia and mild hypophosphatemia. Serum level of intact parathyroid hormone (iPTH) inappropriately increased (141 pg/mL), which was compatible with a primary hyperparathyroidism. Intravenous hydration with normal saline followed by loop diuretics was given immediately. Neck sonograms showed enlargement of the right inferior parathyroid gland (0.7 x 0.6 x 0.6 cm). Echo-guided aspiration cytology reported typical chief cells. Parathyroid adenoma was suspected. Pre-operation localization with 201T1 and 99m Tc subtraction scans showed a focal tracer accumulation in the right lower pole of the thyroid (Fig 1 & 2 ). Bone survey showed no evidence of osteolytic bone lesions in the skull, spine, pelvic and long bones. She underwent surgical exploration of the neck which revealed a soft nodule about one centimeter in diameter located behind the right lower pole of the thyroid gland. The right superior, left superior, and left inferior parathyroid glands appeared normal. The pathology of the nodule confirmed the diagnosis of parathyroid adenoma. Post-operation course was smooth without any hypocalcemic episode. She was discharged and followed up in the OPD.

<Discussion>

副甲狀腺(parathyroid glands)位於甲狀腺附近,通常是由4個腺體組成。原發性副甲狀腺機能亢進症(primary hyperparathyroidism)是高血鈣最常見的原因,每年每十萬人約有42人發現此病,然而超過60歲的女人,每1000人便有4人有原發性副甲狀腺機能亢進症,女性為男性的2-3倍之多。過多的副甲狀腺素(parathyroid hormone,PTH)會增加骨頭再吸收、增加腸道吸收鈣及降低腎臟排泄鈣,而導致高血鈣。

80%的原發性副甲狀腺機能亢進症是因為副甲狀腺瘤(parathyroid adenoma),15%是原發性過度增生(primary hyperplasia),而1-2%是副甲狀腺癌(parathyroid carcinoma)造成的,後者因為常會有相當嚴重的高血鈣及可觸摸到的頸部腫塊,一般於手術前就可以確定。也有可能是家族性內分泌疾病造成4個腺體都過度增生,如多發性內分泌腫瘤(multiple endocrine neoplasia 1 & 2A)及isolated familial hyperparathyroidism。

高血鈣會影響身體許多器官,因此造成諸多症狀及疾病:如對中樞神經系統造成疲勞、憂鬱、精神病、步履不穩、僵呆及昏迷;對神經肌肉造成無力、近端肌病變;對心臟血管形成高血壓、心跳緩慢,縮短QT interval;促進腎臟結石形成、降低腎絲球過濾率、多尿、高血氯性酸中毒、腎鈣化症(nephrocalcinosis);對腸胃道的影響包括噁心、嘔吐、便秘及食慾不振;另可以發現眼睛有帶狀角膜病變(band keratopathy);骨頭會有囊狀纖維性骨炎(osteitis fibrosa cystica)及骨質疏鬆症;也會造成全身轉移性鈣化(systemic metastatic calcification)。然而隨著血液篩檢的普及,這些病人通常是沒有症狀且也大大降低其併發症的發生。

實驗室檢查可以發現高血鈣及低血磷,因為PTH會促進腎臟排泄磷,另外也會出現輕微的高血氯代謝性酸中毒,因此如果血氯與血磷的比值大於33則可以高度懷疑是原發性副甲狀腺機能亢進。當血中intact PTH高於正常值或於正常值上限時就可以診斷為原發性副甲狀腺機能亢進,但是有一個例外-家族性良性低尿鈣高血鈣症(familial benign hypocalciuric hypercalcemia),後者需要再測24小時尿鈣排泄量。因為高骨頭轉換率(high bone turnover),所以alkaline phosphatase值也會上升。

對於高血鈣症危象(hypercalcemia crisis)應該緊急給予治療,包括適當給予輸液及loop diuretics,增加鈣由尿液中排出;再給予雙磷酸鹽類(bisphosphonate)及降鈣素(calcitonin)抑制骨骼之蝕骨作用。當然,最重要是治療潛在的疾病。

最確定的治療是副甲狀腺切除(parathyroidectomy)。有關手術前的定位,目前建議頸部超音波及Tc-99m sestamibi為起始的定位方法,其他尚有核磁共振攝影、血管攝影、細針抽吸等,另外還有T1-201/Tc-99m subtraction scans,主要是由於T1-201可被甲狀腺和副甲狀腺攝取,而Tc-99m會被甲狀腺和唾液腺攝取,將前者的影像減掉後者即可觀察到副甲狀腺腺瘤,如同這位病人。手術切除的併發症包括反喉神經損傷及永久性副甲狀腺低能症,對有經驗的外科醫師而言,其發生率小於1%。

<References>

  1. Hyperparathyroid and hypoparathyroid disorders. N Engl J Med 2000;343:1863.
  2. Hypercalcemia. Curr Probl Surg 2002;39:349.
  3. Therapeutic controversies in primary hyperparathyroidism. J Clin Endocrinol Metab 1999;84:2275. 

繼續教育考題
1.
(C)
下列何疾病是高血鈣最常見的原因?
ABeast cancer
BMultiple myeloma
CPrimary hyperparathyroidism
DThyrotoxicosis
EAdrenal insufficiency
2.
(E)
下列何者是副甲狀腺素造成高血鈣的原因?
A增加骨頭再吸收
B增加腸胃道吸收鈣
C降低腎臟排泄鈣
D促進活性維生素D合成
E以上皆是
3.
(B)
原發性副甲狀腺機能亢進症最常見的原因?
AIsolated familial hyperparathyroidism
BParathyroid adenoma
CPrimary parathyroid hyperplasia
DParathyroid carcinoma
EMEN 2A
4.
(A)
原發性副甲狀腺機能亢進症最常見的症狀?
A無症狀
B多尿
C噁心
D腎臟結石
E心律不整
5.
(D)
以下何者對於原發性副甲狀腺機能亢進症的診斷較無幫助?
ASerum calcium level
BSerum phosphorus level
CIntact PTH level
DSerum magnesium level
ESerum chloride level
6.
(D)
高血鈣併血中intact PTH升高時,仍須排除何者疾病,才可以診斷為原發 性副甲狀腺機能亢進症?
ASarcoidosis
BVitamin D intoxication
CMultiple myeloma
DFamilial benign hypocalciuric hypercalcemia
EMilk-alkali syndrome
7.
(C)
下列何者不建議用於高血鈣危象的治療?
AFluid resuscitation with normal saline
BBisphosphonates
CThiazide diuretics
DCalcitonin
EHemodialysis
8.
(B)
有關副甲狀腺的定位何者建議為先?
AMRI
BUltrasound and Tc-99m sestamibi
CArteriograms
DHighly selective venous catheterization for PTH
EFine-needle aspiration biopsy of suspected parathyroid masses
9.
(A)
原發性副甲狀腺機能亢進症的首選治療?
AParathyroidectomy
BEstrogen replacement therapy
CBisphosphonates
DCalcitonin
ESteroid
10.
(E)
副甲狀腺切除可能造成的併發症?
A反喉神經受損
B永久性副甲狀腺低能症
C局部血腫
D暫時性低血鈣
E以上皆是

答案解析 

  1. (C) Primary hyperparathyroidism is the commonest cause of hypercalcemia.
  2. (E) 以上皆是
  3. (B) Primary hyperparathyroidism is caused by a single parathyroid adenoma in about 80% of cases. 
  4. (A) With the advent of multiphasic screening of serum chemistries, we have come to recognize that primary hyperparathyroidism is a common and usually asymptomatic disorder. 
  5. (D) Diagnostic tests for primary hyperparathyroidism include serum calcium, phosphorus, intact PTH, chloride/phosphate ratio, alkaline phosphatase and 24-hour urinary calcium. 
  6. (D) In a patient with a high PTH level, there is no need to screen for metastatic malignancy, sarcoidosis, multiple myeloma, ect. A determination of urinary calcium concentration and urinary creatinine excretion should be obtained to exclude familial benign hypocalciuric hypercalcemia.
  7. (C) The administration of thiazides and related diuretics such as chlorthalidone can produce an increase in the serum calcium. Saline and loop diuretics can increase urinary calcium excretion. 
  8. (B) Noninvasive localizing studies (Tc-99m sestamibi, ultrasound) are generally used at initial exploration.
  9. (A) The definitive treatment of primary hyperparathyroidism is parathyroidectomy.
  10. (E) 以上皆是。


Top of Page